V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 230000319 | 230000187 | 1.46 | 54.4 | Adjuvant (A) | 2013-03-08 | 2013-03-22 | CAPECITABINE + MITOMYCIN + RT | N | N | 230001311 | FLUOROURACIL |
| 230000320 | 230001120 | 1.7 | 67.5 | Curative (C) | null | 2014-08-30 | Cisplatin + Doxorubicin | N | Y | 230001336 | CAPECITABINE + OXALIPLATIN |
| 230000321 | 230000188 | 1.67 | 88 | Palliative (P) | 2014-12-16 | 2014-12-28 | Irinotecan + Modified De Gramont | 02 | N | 230001346 | FLUOROURACIL + MITOMYCIN + RT |
| 230000322 | 230001121 | null | 70 | Palliative (P) | 2015-11-08 | 2015-11-22 | Sorafenib | N | null | 230001387 | IRINOTECAN + MDG |
| 230000323 | 230001121 | 1.63 | 97.8 | Neo-adjuvant (N) | 2018-05-05 | 2018-05-26 | Fluorouracil+Mitomycin+RT (Anal Ca) | N | Y | 230001387 | CAPECITABINE + RT |
| 230000324 | 230000189 | 1.58 | null | Neo-adjuvant (N) | 2015-03-08 | 2015-04-07 | Carboplatin AUC 2 - 5 | N | Y | 230001436 | PACLITAXEL |
| 230000325 | 230000189 | 1.53 | 33 | Neo-adjuvant (N) | 2013-12-21 | 2014-02-07 | Capecitabine + Oxaliplatin 21day | N | N | 230001436 | FLUOROURACIL + MITOMYCIN + RT |
| 230000326 | 230000189 | 1.53 | 66.4 | Adjuvant (A) | 2016-11-26 | 2016-12-12 | Sorafenib | N | N | 230001436 | MYELOMA XI TRIAL |
| 230000327 | 230000190 | 1.71 | 74 | Palliative (P) | 2015-10-10 | 2015-10-30 | CAPECITABINE + OXALIPLATIN | N | N | 230001490 | CAPECITABINE |
| 230000328 | 230000190 | 1.82 | null | Adjuvant (A) | 2013-04-30 | 2013-05-18 | BENDAMUSTINE + RITUXIMAB | N | N | 230001490 | OXALIPLATIN + MDG |
| 230000329 | 230000190 | 1.62 | 90.6 | Palliative (P) | 2016-06-21 | 2016-06-21 | Fluorouracil+Mitomycin+RT (Anal Ca) | 2 | N | 230001490 | TRIAL |
| 230000330 | 230000190 | 1.67 | null | Curative (C) | 2016-11-07 | 2016-10-17 | Fluorouracil + Folinic Acid Weekly | N | null | 230001490 | CAPECITABINE + MITOMYCIN + RT |
| 230000331 | 230000191 | 1.79 | 76 | Palliative (P) | 2016-06-05 | 2016-06-08 | Cisplatin + Doxorubicin | N | N | 230001516 | FLUOROURACIL |
| 230000332 | 230000192 | 1.58 | 57.6 | Neo-adjuvant (N) | 2017-12-18 | 2018-01-09 | VANDETANIB | N | N | 230001527 | CAPECITABINE + RT |
| 230000333 | 230000193 | 1.61 | 103 | Curative (C) | null | 2015-03-06 | Carboplatin + Etoposide iv&po | 99 | Y | 230001544 | CAPECITABINE + RT |
| 230000334 | 230000194 | 1.83 | 68.7 | Curative (C) | 2015-08-30 | 2015-09-12 | Carboplatin + Pemetrexed | N | Y | 230001578 | CAPECITABINE + OXALIPLATIN |
| 230000335 | 230000194 | 1.59 | 69 | Adjuvant (A) | 2016-02-14 | 2016-02-16 | CAPECITABINE + MITOMYCIN + RT | N | N | 230001578 | CAPECITABINE + OXALIPLATIN |
| 230000336 | 230000194 | 1.73 | 79.5 | null | 2014-12-22 | 2014-12-26 | CABOZANTINIB | null | null | 230001578 | CAP + RT |
| 230000337 | 230000194 | 1.8 | 89 | Curative (C) | 2015-10-02 | 2015-10-08 | Carboplatin AUC 2 - 5 | N | N | 230001578 | CAPECITABINE |
| 230000338 | 230000195 | 1.74 | 109.9 | Disease modification (D) | 2018-11-25 | 2018-11-28 | FLUOROURACIL + MITOMYCIN + RT | 02 | N | 230001658 | CAPECITABINE + RT |
| 230000339 | 230000196 | 1.83 | 79.6 | Palliative (P) | 2014-06-14 | 2014-06-28 | Capecitabine (14 day) + Irinotecan | N | N | 230001683 | FLUOROURACIL + MITOMYCIN + RT |
| 230000340 | 230001125 | 1.65 | 50.8 | Curative (C) | 2014-09-01 | 2014-09-22 | VANDETANIB | N | null | 230001693 | FLUOROURACIL + MITOMYCIN + RT |
| 230000341 | 230001125 | 1.74 | 73.2 | Adjuvant (A) | 2013-03-06 | 2013-03-10 | Oxaliplatin + Modified de Gramont | 2 | N | 230001693 | VANDETANIB |
| 230000342 | 230001125 | 1.73 | 59.7 | Palliative (P) | 2010-12-11 | 2014-02-04 | Capecitabine + Oxaliplatin 14day | N | N | 230001693 | OXALIPLATIN + MDG |
| 230000343 | 230000197 | 1.63 | 64 | Palliative (P) | 2018-03-10 | 2018-03-18 | Fluorouracil+Mitomycin+RT (Anal Ca) | N | N | 230001759 | FLUOROURACIL |
| 230000344 | 230000198 | 1.57 | null | Curative (C) | 2014-01-16 | 2014-01-20 | CAPECITABINE + OXALIPLATIN | 02 | null | 230001780 | OXALIPLATIN + MDG |
| 230000345 | 230000199 | null | 60.9 | Adjuvant (A) | 2015-05-26 | 2015-05-26 | Oxaliplatin + Modified de Gramont | null | null | 230001788 | OXALIPLATIN + MDG |
| 230000346 | 230000199 | null | null | Neo-adjuvant (N) | 2017-07-12 | 2017-07-12 | Carboplatin + Etoposide iv&po | N | null | 230001788 | CAPECITABINE + OXALIPLATIN |
| 230000347 | 230000200 | null | 110 | Adjuvant (A) | 2014-09-18 | 2014-10-13 | CISPLATIN + RT | N | null | 230001878 | IRINOTECAN + MDG |
| 230000348 | 230000201 | 1.66 | 58.9 | Adjuvant (A) | 2016-02-24 | 2016-02-26 | Oxaliplatin + Modified de Gramont | 02 | N | 230001889 | CAPECITABINE + RT |
| 230000349 | 230000202 | 1.71 | 56.5 | null | 2015-08-11 | 2015-08-11 | Bevacizumab + Cape + Oxali 14day | 2 | N | 230001917 | UKALL2014 |
| 230000350 | 230000203 | 1.61 | 63.2 | Neo-adjuvant (N) | 2013-07-06 | 2013-07-26 | Capecitabine | N | null | 230001937 | CAPECITABINE + OXALIPLATIN |
| 230000351 | 230000203 | 1.71 | 61.6 | Not known (9) | 2014-01-31 | 2014-01-31 | Sorafenib | N | N | 230001937 | CARBOPLATIN + PACLITAXEL |
| 230000352 | 230000203 | null | 87.5 | Adjuvant (A) | 2014-07-08 | 2014-07-23 | Docetaxel | 2 | N | 230001937 | CAPECITABINE + OXALIPLATIN |
| 230000353 | 230000204 | 1.53 | 61 | Adjuvant (A) | 2015-04-27 | 2015-05-17 | VANDETANIB | 02 | N | 230002010 | OXALIPLATIN + RALTITREXED |
| 230000354 | 230001128 | 1.78 | 84.6 | Not known (9) | 2016-01-20 | 2016-01-24 | EOX | N | null | 230002017 | OXALIPLATIN + MDG |
| 230000355 | 230001128 | 1.6 | null | Palliative (P) | 2013-07-16 | 2013-07-16 | Temozolomide + RT | N | N | 230002017 | CAPECITABINE |
| 230000356 | 230001647 | 1.7 | 66.6 | Adjuvant (A) | 2016-09-15 | 2016-09-15 | Rituximab | 02 | N | 230002040 | BEVACIZUMAB + CAPECITABINE |
| 230000357 | 230001647 | 1.68 | 62.7 | Adjuvant (A) | 2015-02-07 | 2015-02-27 | Oxaliplatin + Modified de Gramont | 02 | N | 230002040 | CAPECITABINE + OXALIPLATIN |
| 230000358 | 230000205 | 1.5 | 69.45 | Adjuvant (A) | 2015-11-11 | 2015-11-12 | Cisplatin + Doxorubicin | 02 | N | 230002091 | FLUOROURACIL |
| 230000359 | 230000206 | null | null | Curative (C) | 2015-03-24 | 2015-04-04 | R GCVP | N | Y | 230002108 | OXALIPLATIN + MDG |
| 230000360 | 230000206 | 1.83 | 92 | Not known (9) | 2017-05-09 | 2017-05-26 | CHOP R - 21 days | N | N | 230002108 | CAPECITABINE + OXALIPLATIN |
| 230000361 | 230000207 | 1.71 | 0 | null | 2014-12-25 | 2015-01-27 | Fluorouracil + Folinic Acid Weekly | N | N | 230002114 | CAPECITABINE |
| 230000362 | 230000208 | 1.76 | 74.7 | Curative (C) | 2014-05-16 | 2014-05-16 | Cisplatin + Pemetrexed | 02 | Y | 230002123 | CAPECITABINE |
| 230000363 | 230000209 | 1.6 | 99 | Adjuvant (A) | null | 2016-05-01 | Trastuzumab Subcutaneous | 1 | N | 230002135 | CAPECITABINE + OXALIPLATIN |
| 230000364 | 230000210 | 1.64 | null | Neo-adjuvant (N) | 2015-01-09 | 2015-01-14 | CAPECITABINE + OXALIPLATIN | 02 | N | 230002159 | CVP R |
| 230000365 | 230000211 | 1.63 | 81 | null | 2014-01-29 | 2014-02-02 | Carboplatin + Etoposide IV 3 day | N | null | 230002226 | CAPECITABINE + OXALIPLATIN |
| 230000366 | 230000212 | 1.63 | 83.9 | Adjuvant (A) | null | 2017-07-22 | CABOZANTINIB | N | N | 230002231 | CAPECITABINE + OXALIPLATIN |
| 230000367 | 230000213 | 1.63 | 45.2 | null | 2018-03-21 | 2018-04-06 | VANDETANIB | 02 | null | 230002250 | IRINOTECAN + MDG |
| 230000368 | 230000214 | 1.68 | 60.8 | Neo-adjuvant (N) | 2018-04-23 | 2018-04-26 | Oxaliplatin + Modified de Gramont | 02 | Y | 230002257 | IRINOTECAN + MDG |